Proficio Capital Partners LLC Invests $95,000 in The Cooper Companies, Inc. (NASDAQ:COO)

Proficio Capital Partners LLC acquired a new stake in The Cooper Companies, Inc. (NASDAQ:COO) during the fourth quarter, Holdings Channel reports. The institutional investor acquired 94,504 shares of the medical device company’s stock, valued at approximately $95,000.

A number of other institutional investors have also made changes to their positions in COO. Fulton Bank N.A. increased its stake in Cooper Companies by 3.0% in the 4th quarter. Fulton Bank N.A. now owns 3,718 shares of the medical device company’s stock valued at $342,000 after buying an additional 109 shares during the last quarter. Mather Group LLC. grew its holdings in shares of Cooper Companies by 7.4% in the 4th quarter. Mather Group LLC. now owns 1,926 shares of the medical device company’s stock valued at $177,000 after acquiring an additional 133 shares in the last quarter. MassMutual Private Wealth & Trust FSB grew its holdings in shares of Cooper Companies by 15.6% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,008 shares of the medical device company’s stock valued at $93,000 after acquiring an additional 136 shares in the last quarter. Greenleaf Trust increased its position in shares of Cooper Companies by 5.0% in the fourth quarter. Greenleaf Trust now owns 2,915 shares of the medical device company’s stock valued at $268,000 after acquiring an additional 139 shares during the last quarter. Finally, UMB Bank n.a. raised its holdings in Cooper Companies by 22.5% during the fourth quarter. UMB Bank n.a. now owns 773 shares of the medical device company’s stock worth $71,000 after acquiring an additional 142 shares in the last quarter. Institutional investors own 24.39% of the company’s stock.

Cooper Companies Trading Down 1.7 %

COO opened at $77.73 on Friday. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12. The Cooper Companies, Inc. has a fifty-two week low of $77.05 and a fifty-two week high of $112.38. The company’s 50 day moving average price is $91.67 and its two-hundred day moving average price is $99.11. The firm has a market capitalization of $15.51 billion, a price-to-earnings ratio of 39.86, a PEG ratio of 2.25 and a beta of 1.02.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings data on Thursday, March 6th. The medical device company reported $0.92 earnings per share for the quarter, hitting the consensus estimate of $0.92. The company had revenue of $964.70 million for the quarter, compared to analysts’ expectations of $981.25 million. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. As a group, research analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on COO. StockNews.com cut Cooper Companies from a “buy” rating to a “hold” rating in a report on Wednesday, December 11th. Robert W. Baird dropped their price objective on Cooper Companies from $117.00 to $107.00 and set an “outperform” rating for the company in a report on Friday, March 7th. Needham & Company LLC reissued a “hold” rating on shares of Cooper Companies in a report on Friday, March 7th. Stifel Nicolaus dropped their price target on Cooper Companies from $115.00 to $105.00 and set a “buy” rating for the company in a research note on Friday, March 7th. Finally, Piper Sandler reiterated an “overweight” rating and set a $115.00 price objective (down from $120.00) on shares of Cooper Companies in a research note on Friday, March 7th. Three investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $111.89.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.